ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

AACR To Screen Attendees From SARS-Affected Areas.

June 20, 2003

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

In Brief: NIH Peer Review Reorganization Proposed By Advisory Panel; Comments Sought

September 3, 1999

In Brief: Riley Becomes ACCC president; Rep. Green Urges Support Of Cancer Treatment Act

April 9, 1999

In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

February 21, 2014